The effect of vitamin D in bronchiectasis

Investigation the effect of oral vitamin D compared to placebo in the treatment of brochiectasis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017022532771N1

Enrollment

Registered

2017-03-08

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis. Bronchiectasis

Interventions

Intervention 1: Vitamin D group: 50000 I/U oral vtamin D once a week for 2 months. Intervention 2: Placebo group: 300 mg of starch once a day for 2 months.

Treatment - Drugs

Placebo

Vitamin D group: 50000 I/U oral vtamin D once a week for 2 months

Placebo group: 300 mg of starch once a day for 2 months.

Eligibility

Sex/Gender

All

Age

21 Years to 139 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age of more than 21 years; having bronchiectasis; having vitamin D deficiency. Exclusion criteria: having cardiac or renal diseases; diabetes; other pulmonary diseases; uncontrolled hypertension.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Number of attacks. Timepoint: At the end of second month. Method of measurement: By asking the patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Bagher Maleki

Zahedan University of Medical Sciences

m.maleki@zaums.ac.ir, salehmaleki28@yahoo.com, ayubabedi48@gmail.com+98 54 3322 5715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026